Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Labguru announces $1M pro-bono program for COVID-19 treatment developers

By Heather Hall | April 15, 2020

BioData is offering a pro-bono program allowing free access to its flagship Labguru electronic laboratory notebook (ELN) to academic laboratories, nonprofit organizations and small start-ups working on COVID-19 treatment or vaccine development, up to a total value of $1M.

The offer comes hot on the heels of the LabRoom video conferencing service introduced free of charge to all customers last week and includes the BioData team’s commitment to rapid set up and support, as well as free access to the Labguru Academy library.

Jonathan Gross, founder and CTO of BioData said: “Fighting the COVID-19 pandemic is the most important global effort of our time. We are keen to support scientific research by doing our part.”

With its out-of-the-box easy setup, Labguru ELN allows more efficient lab operations and improved research output. It streamlines the planning and documenting of experiments, tracking progress, simplifying lab logistics, and sharing results.

Labguru was designed from the outset to be deployed across an entire organization within days, with seamless migration from other systems, a straightforward training program and direct access to our support function. The platform has earned its reputation, and is already used by more than 80,000 researchers worldwide to accelerate laboratory output, improve inventory management and support remote collaboration.

“By granting free access to the Labguru platform at this time, we are looking to support vital COVID-19 vaccine development initiatives from the ground up, whether led by academic institutions, not-for-profit organizations or small start-ups, who may not be able to easily access this supporting technology. Tools like Labguru are invaluable in helping speed up research development and lab work, especially during social distancing and limited laboratory access,” said Gross.

Lab work planning and resource management are made simple through an integrated automated laboratory inventory management system and remote sample management, as well as the ability to connect the ELN with the equipment management system.

Labguru is compliant with FDA 21 CFR Part 11 regulations and provides a full audit trail.

To apply for a free Labguru account visit, labguru.com/covid-19.

Related Articles Read More >

The power of saliva in multi-omics biomarker discovery
Japanese drug shows promise in preventing COVID-19 infection
Chinese researchers uncover new bat virus HKU5-CoV-2 that shares COVID‑19’s entry pathway
Johns Hopkins APL model highlights testing’s role in pandemic response
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE